Skip to main content
. 2021 Apr 19;10(2):783–808. doi: 10.1007/s40122-021-00260-1

Table 6.

Indications on the selection of the most adequate NSAID according to the cardiovascular and gastrointestinal risk, in patients with high renal risk

High renal risk
CV risk GI risk
Low High
Low Diclofenac/other selective COX-2 inhibitors at the lowest effective level, for no longer than 7 to 10 days Any NSAID
High Any NSAID Any NSAID
High + LDA Any NSAID Any NSAID

In italics, compounds indicated based on the available randomized controlled trials. Underlined, compounds contraindicated based on the available randomized controlled trials

GI gastrointestinal, COX-2 cyclooxygenase, NSAID non-steroidal anti-inflammatory drug, CV cardiovascular, LDA low-dose aspirin